These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 29770366

  • 21. Left atrial thrombus under dabigatran in a patient with nonvalvular atrial fibrillation.
    Janssen AM, van de Kerkhof D, Szabó B, Durian MF, van der Voort PH.
    Neth J Med; 2016 Aug; 74(7):313-5. PubMed ID: 27571947
    [Abstract] [Full Text] [Related]

  • 22. Left atrial appendage thrombus with resulting stroke post-RF ablation for atrial fibrillation in a patient on dabigatran.
    Lobo R, McCann C, Hussaini A, Meany TB, Kiernan TJ.
    Ir Med J; 2014 Aug; 107(10):329-30. PubMed ID: 25551903
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A novel coagulation parameter monitoring bleeding tendency of Chinese nonvalvular atrial fibrillation patients prescribing dabigatran etexilate.
    Wang H, Zhou Y, Rong G, Lu L, Zhang J.
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):563-7. PubMed ID: 26881855
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Effect of non-vitamin K antagonist oral anticoagulants on left atrial or atrial appendage thrombi in patients with nonvalvular atrial fibrillation].
    Cui J, Du X, Wu JH, Jia CQ, Li X, Ning M, Lyu J, Yang Y, Liu XH, Dong JZ, Ma CS.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Aug 24; 46(8):606-610. PubMed ID: 30139010
    [Abstract] [Full Text] [Related]

  • 27. Interatrial block to predict atrial fibrillation in myotonic dystrophy type 1.
    Russo V, Papa AA, Rago A, Ciardiello C, Marano M, Proietti R, Politano L, Nigro G.
    Neuromuscul Disord; 2018 Apr 24; 28(4):327-333. PubMed ID: 29567351
    [Abstract] [Full Text] [Related]

  • 28. Outcome of Anticoagulation Therapy of Left Atrial Thrombus or Sludge in Patients With Nonvalvular Atrial Fibrillation or Flutter.
    Yang Y, Du X, Dong J, Ma C.
    Am J Med Sci; 2019 Oct 24; 358(4):273-278. PubMed ID: 31543101
    [Abstract] [Full Text] [Related]

  • 29. Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary.
    Waks JW, Zimetbaum PJ.
    Expert Rev Cardiovasc Ther; 2013 Nov 24; 11(11):1461-71. PubMed ID: 24147516
    [Abstract] [Full Text] [Related]

  • 30. [Atrial and left atrial appendage thrombosis in patients with atrial fibrillation: from pathophysiology to treatment].
    Calabrò P, Gragnano F, Cesaro A, Pariggiano I, Patti G, Cavallari I, Parato VM, Renda G, De Caterina R, a nome del Gruppo di Studio sulla Trombosi della Società Italiana di Cardiologia.
    G Ital Cardiol (Rome); 2019 Jun 24; 20(6):374-383. PubMed ID: 31184324
    [Abstract] [Full Text] [Related]

  • 31. Risk factors for thrombosis and spontaneous echocardiographic contrast with sludge in atrial fibrillation patients treated with oral anticoagulants before electrical cardioversion.
    Rekosz J, Karwowski J, Kowalik I, Wiktorska A, Wrzosek K, Solecki M, Szmarowska K, Szymańska A, Mierzejewska B, Syska-Sumińska J, Dłużniewski M.
    Kardiol Pol; 2024 Jun 24; 82(5):516-526. PubMed ID: 38606742
    [Abstract] [Full Text] [Related]

  • 32. Dabigatran for stroke prevention in real life in a sample of population from Turkey: D-SPIRIT registry.
    Altın C, Topaloğlu C, Çetin N, Dalgıç O, Yavuz V, Alioğlu E, Bilgin N, Ekmekçi C, Pekel N, Özpelit ME, Tunçer E, Türkoğlu Eİ, Tülüce K, Kocabaş U, Yüksel K, Türk UÖ.
    Turk Kardiyol Dern Ars; 2021 Dec 24; 49(8):630-640. PubMed ID: 34881702
    [Abstract] [Full Text] [Related]

  • 33. [Modern Approaches to Prevention of Thromboembolic Complications in Patients With Nonvalvular Atrial Fibrillation With a Direct Thrombin Inhibitor Dabigatran].
    Savina NM.
    Kardiologiia; 2016 Jul 24; 56(7):91-99. PubMed ID: 28290913
    [Abstract] [Full Text] [Related]

  • 34. Non-vitamin K oral anticoagulants versus warfarin for left atrial appendage thrombus resolution in nonvalvular atrial fibrillation or flutter.
    Hussain A, Katz WE, Genuardi MV, Bhonsale A, Jain SK, Kancharla K, Saba S, Shalaby AA, Voigt AH, Wang NC.
    Pacing Clin Electrophysiol; 2019 Sep 24; 42(9):1183-1190. PubMed ID: 31355470
    [Abstract] [Full Text] [Related]

  • 35. Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study.
    Pallisgaard JL, Lindhardt TB, Hansen ML, Schjerning AM, Olesen JB, Staerk L, Torp-Pedersen C, Gislason GH.
    PLoS One; 2015 Sep 24; 10(10):e0141377. PubMed ID: 26513589
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and safety of dabigatran and rivaroxaban in atrial fibrillation patients with impaired liver function: a multicenter retrospective cohort study.
    Huang X, Xu W, Wu G, Li R, Gu P, Zheng Q, Liu X, Dai H, Lin X, Liu Y, Du X, Su J, Zhang W, Zhang M, Zhu Z, Huang X, Huang N, Zhang J.
    Eur J Clin Pharmacol; 2024 Aug 24; 80(8):1141-1150. PubMed ID: 38605248
    [Abstract] [Full Text] [Related]

  • 37. Incidence of left atrial abnormalities under treatment with dabigatran, rivaroxaban, and vitamin K antagonists.
    Reers S, Agdirlioglu T, Kellner M, Borowski M, Thiele H, Waltenberger J, Reppel M.
    Eur J Med Res; 2016 Oct 21; 21(1):41. PubMed ID: 27769294
    [Abstract] [Full Text] [Related]

  • 38. Bachmann bundle pacing reduces atrial electromechanical delay in type 1 myotonic dystrophy patients.
    Russo V, Rago A, Papa AA, Arena G, Politano L, Nigro G.
    J Interv Card Electrophysiol; 2018 Apr 21; 51(3):229-236. PubMed ID: 29488106
    [Abstract] [Full Text] [Related]

  • 39. Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting.
    Cannon CP, Gropper S, Bhatt DL, Ellis SG, Kimura T, Lip GY, Steg PG, Ten Berg JM, Manassie J, Kreuzer J, Blatchford J, Massaro JM, Brueckmann M, Ferreiros Ripoll E, Oldgren J, Hohnloser SH, RE-DUAL PCI Steering Committee and Investigators.
    Clin Cardiol; 2016 Oct 21; 39(10):555-564. PubMed ID: 27565018
    [Abstract] [Full Text] [Related]

  • 40. Atrial Thrombosis Prevalence Before Cardioversion or Catheter Ablation of Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists.
    Troisi F, Guida P, Vitulano N, Quadrini F, Di Monaco A, Patti G, Grimaldi M.
    Am J Cardiol; 2024 May 01; 218():77-85. PubMed ID: 38458580
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.